clonidine has been researched along with valproic acid in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (17.95) | 18.7374 |
1990's | 10 (25.64) | 18.2507 |
2000's | 13 (33.33) | 29.6817 |
2010's | 8 (20.51) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Dalton, CR; Dudley, MW; Kane, JM; Kehne, JH; Ketteler, HJ; McCloskey, TC; Miller, FP; Ogden, AM; Senyah, Y; Staeger, MA | 1 |
Nezu, JI; Ohashi, R; Oku, A; Sai, Y; Shimane, M; Tamai, I; Tsuji, A; Yabuuchi, H | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Cuddon, P; Fleming, A; Floto, RA; Goldsmith, P; Jahreiss, L; O'Kane, CJ; Pask, D; Rubinsztein, DC; Saiki, S; Sarkar, S; Siddiqi, FH; Ttofi, EK; Williams, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Hansson, E; Nilsson, M; Rönnbäck, L | 1 |
de Chiara, BM; Genazzani, AD; Genazzani, AR; Montemagno, R; Montemagno, U; Nappi, C; Petraglia, F | 1 |
Andreev, BV; Ignatov, IuD | 1 |
Cookson, JC | 1 |
Dirksen, R; Van der Laan, JW | 1 |
Green, AR; Johnson, P; Mountford, JA; Nimgaonkar, VL | 1 |
Lerer, B | 1 |
Hillen, FC; van der Laan, JW; Weick, G | 1 |
Bremner, KE; Naranjo, CA; Ozdemir, V | 1 |
Bhatara, VS; Carrera, J | 1 |
Kazamatsuri, H | 1 |
Dilsaver, SC; Minkus, D; Swann, AC | 1 |
de Angelis, L | 1 |
Louie, J; Oftadeh, LC; Oh, C; Song, CH; Yu, KT | 1 |
Cohen, D; Flament, MF; Gérardin, P; Mazet, P | 1 |
Cummings, MR; Miller, BD | 1 |
Mendhekar, DN | 1 |
Cummins, TK; Kratochvil, CJ; Martin, A; Varley, C | 1 |
Clausen, T; Isaksen, A; Kristensen, Ø; Lølandsmo, T; Vederhus, JK | 1 |
D'Amico, D | 1 |
Bamford, A; Clarke, A; Crowe, BH; Hacohen, Y; Lim, M; Lin, JP; Pullaperuma, SP; Sancho-Shimizu, V; Tudor-Williams, G; Vincent, A | 1 |
Clausen, T; Dunsæd, F; Høie, MM; Kristensen, Ø; Vederhus, JK | 1 |
Fontaine, GV; Fraser, GL; Gagnon, DJ; Riker, RR | 1 |
Aletraris, L; Paino, M; Roman, PM | 1 |
7 review(s) available for clonidine and valproic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug treatment of bipolar depression and mania.
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Bromocriptine; Carbamazepine; Cholinesterase Inhibitors; Clonidine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Humans; Lithium; Monoamine Oxidase Inhibitors; Phosphatidylcholines; Tryptophan; Valproic Acid; Verapamil | 1985 |
Alternative therapies for bipolar disorder.
Topics: Ascorbic Acid; Bipolar Disorder; Bupropion; Carbamazepine; Choline; Clonazepam; Clonidine; Clorgyline; Demeclocycline; Fenfluramine; Humans; Methylene Blue; Phosphatidylcholines; Physostigmine; Propiophenones; Propranolol; Spironolactone; Thyroxine; Tryptophan; Valproic Acid | 1985 |
Treatment of alcohol withdrawal syndrome.
Topics: Adrenergic beta-Antagonists; Benzodiazepines; Carbamazepine; Clonidine; Ethanol; Humans; Substance Withdrawal Syndrome; Valproic Acid | 1994 |
[Tardive dyskinesia--diagnosis and treatment].
Topics: Clonidine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Middle Aged; Psychotropic Drugs; Valproic Acid | 1993 |
Pharmacologic management of behavioral instability in medically ill pediatric patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Analgesics, Non-Narcotic; Behavior Therapy; Behavioral Medicine; Benzodiazepines; Carbamazepine; Central Nervous System Stimulants; Child; Clonidine; Diphenhydramine; Histamine H1 Antagonists; Humans; Lithium; Methylphenidate; Psychomotor Agitation; Valproic Acid | 2004 |
Repurposing Valproate, Enteral Clonidine, and Phenobarbital for Comfort in Adult ICU Patients: A Literature Review with Practical Considerations.
Topics: Administration, Oral; Administration, Sublingual; Adult; Clonidine; Critical Illness; Drug Repositioning; Humans; Hypnotics and Sedatives; Intensive Care Units; Patient Comfort; Phenobarbital; Valproic Acid | 2017 |
2 trial(s) available for clonidine and valproic acid
Article | Year |
---|---|
The effect of various drugs with neuroendocrine activity and transdermal estradiol on plasma gonadotropin concentrations after ovariectomy in reproductive-aged women.
Topics: Administration, Cutaneous; Adult; Climacteric; Clonidine; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Lisuride; Luteinizing Hormone; Ovariectomy; Valproic Acid | 1991 |
Treatment of polydrug-using opiate dependents during withdrawal: towards a standardisation of treatment.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Buprenorphine; Carbamazepine; Clonidine; Comorbidity; Drug Therapy, Combination; Female; Hospitalization; Humans; Male; Opioid-Related Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome; Valproic Acid | 2006 |
30 other study(ies) available for clonidine and valproic acid
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
5-Aryl-3-(alkylthio)-4H-1,2,4-triazoles as selective antagonists of strychnine-induced convulsions and potential antispastic agents.
Topics: Animals; Anticonvulsants; Cerebellum; Cerebral Cortex; Chlorides; Electroshock; Flumazenil; Male; Mice; Molecular Structure; Muscle Spasticity; Paralysis; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship; Strychnine; Triazoles | 1994 |
Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance.
Topics: Biological Transport, Active; Carnitine; Carrier Proteins; Cations; Cells, Cultured; Dose-Response Relationship, Drug; Embryo, Mammalian; Humans; Hydrogen-Ion Concentration; Kidney; Membrane Proteins; Organic Cation Transport Proteins; Sodium; Solute Carrier Family 22 Member 5; Stereoisomerism | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imidazoline Receptors; Minoxidil; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Type C Phospholipases; Verapamil | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Receptor-coupled uptake of valproate in rat astroglial primary cultures.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Animals, Newborn; Astrocytes; Biological Transport; Cells, Cultured; Cerebral Cortex; Clonidine; Drug Interactions; Glutamates; Glutamic Acid; Isoproterenol; Kainic Acid; Ketanserin; Phenylephrine; Prazosin; Quinoxalines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Serotonin; Valproic Acid; Yohimbine | 1992 |
[Role of opioid and adrenergic mechanisms in the analgesic action of GABA-positive drugs].
Topics: 4-Aminobutyrate Transaminase; Analgesics; Animals; Baclofen; Clonidine; Drug Tolerance; Female; Male; Morphine; Nociceptors; Pain Measurement; Rats; Receptors, Adrenergic, alpha; Receptors, GABA-A; Valproic Acid | 1988 |
Dipropylacetate-induced shaking behaviour in the rat: a role of spinal alpha 2-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Animals; Behavior, Animal; Clonidine; Dioxanes; Idazoxan; Injections, Intraventricular; Male; Motor Activity; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Spinal Cord; Valproic Acid | 1988 |
Some anticonvulsant drugs alter monoamine-mediated behaviour in mice in ways similar to electroconvulsive shock; implications for antidepressant therapy.
Topics: 5-Hydroxytryptophan; Animals; Anticonvulsants; Antidepressive Agents; Apomorphine; Behavior, Animal; Biogenic Amines; Clonidine; Diazepam; Electroshock; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred C57BL; Motor Activity; Radioligand Assay; Receptors, Adrenergic, beta; Receptors, Serotonin; Valproic Acid | 1985 |
Dipropylacetate-induced quasi-morphine abstinence behaviour in the rat: suppression by alpha 2-adrenoceptor stimulation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Clonidine; Humans; Male; Morphine; Motor Activity; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Valproic Acid | 1983 |
Medications for aggressiveness.
Topics: Aggression; Carbamazepine; Child; Child Behavior Disorders; Clonidine; Electroencephalography; Hallucinations; Humans; Male; Valproic Acid | 1994 |
Chronic treatment with valproate decreases the hypothermic response to clonidine.
Topics: Animals; Body Temperature; Clonidine; Male; Rats; Rats, Sprague-Dawley; Valproic Acid | 1993 |
Effects of valproate and lorazepam on experimental anxiety: tolerance, withdrawal, and role of clonidine.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Clonidine; Drug Tolerance; Female; Injections, Intraperitoneal; Lorazepam; Mice; Substance Withdrawal Syndrome; Valproic Acid | 1995 |
Successful treatment of steroid-resistant chorea associated with lupus by use of valproic acid and clonidine-HCL patch.
Topics: Administration, Oral; Adolescent; Chorea; Clonidine; Female; Humans; Injections, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Prednisone; Valproic Acid | 1997 |
Drug treatment of conduct disorder in young people.
Topics: Adolescent; Adrenergic alpha-Agonists; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Central Nervous System Stimulants; Child; Child Behavior Disorders; Child, Preschool; Clonidine; Conduct Disorder; Humans; Lithium; Randomized Controlled Trials as Topic; Valproic Acid | 2002 |
Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child.
Topics: Age Factors; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Gynecomastia; Humans; Hyperprolactinemia; Male; Methylphenidate; Seizures; Valproic Acid | 2005 |
Less is more: inpatient management of a child with complex pharmacotherapy.
Topics: Aggression; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Depression; Dibenzothiazepines; Domestic Violence; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Irritable Mood; Length of Stay; Male; Methylphenidate; Patient Admission; Psychiatric Department, Hospital; Psychomotor Agitation; Psychotropic Drugs; Quetiapine Fumarate; Recurrence; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Valproic Acid | 2006 |
Pharmacological prophylaxis of chronic migraine: a review of double-blind placebo-controlled trials.
Topics: Amines; Analgesics; Chronic Disease; Clonidine; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Double-Blind Method; Fructose; GABA Agents; Gabapentin; gamma-Aminobutyric Acid; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Topiramate; Valproic Acid | 2010 |
Pediatric Herpes Simplex Virus Encephalitis Complicated by N-Methyl-D-aspartate Receptor Antibody Encephalitis.
Topics: Acyclovir; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiviral Agents; Autoantibodies; Clonidine; Diazepam; Encephalitis, Herpes Simplex; Encephalomalacia; Female; Fever; Humans; Immunocompromised Host; Immunosuppression Therapy; Infant; Leukoencephalopathies; Movement Disorders; Neurological Rehabilitation; Pakistan; Paresis; Phenobarbital; Phenytoin; Plasmapheresis; Receptors, N-Methyl-D-Aspartate; Seizures; Trihexyphenidyl; United Kingdom; Valproic Acid | 2015 |
Standardised detoxification in cases of polydrug use.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Adult; Aged; Anticonvulsants; Clonidine; Cohort Studies; Female; Humans; Male; Middle Aged; Norway; Patient Dropouts; Program Evaluation; Socioenvironmental Therapy; Substance Withdrawal Syndrome; Substance-Related Disorders; Treatment Outcome; Valproic Acid; Young Adult | 2016 |
The use of off-label medications in substance abuse treatment programs.
Topics: Accreditation; Adrenergic alpha-2 Receptor Agonists; Anticonvulsants; Antiemetics; Baclofen; Clonidine; Excitatory Amino Acid Antagonists; GABA Agents; Gabapentin; Health Facility Size; Humans; Logistic Models; Off-Label Use; Ondansetron; Practice Patterns, Physicians'; Substance Abuse Treatment Centers; Substance-Related Disorders; Time Factors; Topiramate; United States; Valproic Acid | 2020 |